Protect Your Newborn from Inherited Bleeding Disorders
As expectant parents or new caregivers, the thought of your baby facing health challenges can be overwhelming. When it comes to platelet disorders that affect blood clotting, early detection through our ITGA2B Gene Thrombocytopenia test provides the clarity and peace of mind every family deserves.
Understanding the ITGA2B Thrombocytopenia DNA Test
This specialised genetic test examines the ITGA2B gene, which plays a crucial role in platelet function. When this gene has variations, it can lead to neonatal alloimmune thrombocytopenia – a condition where a mother’s antibodies attack her baby’s platelets. Our advanced Next Generation Sequencing (NGS) technology provides the most accurate analysis available, giving you definitive answers about your newborn’s genetic risk factors.
Who Should Consider This Important Test?
This test is particularly important if you or your family have experienced:
- Unexplained bruising or bleeding in newborns
- Family history of platelet disorders or bleeding conditions
- Previous pregnancies affected by neonatal thrombocytopenia
- Concerns about inherited bleeding risks in your newborn
- Planning for future pregnancies with known genetic risks
Why Early Detection Matters for Your Baby’s Health
Identifying ITGA2B gene variations early provides significant benefits:
- Prevent Serious Complications: Early diagnosis helps prevent intracranial bleeding and other serious bleeding events
- Personalised Care Planning: Enables healthcare providers to create tailored monitoring and treatment plans
- Family Planning Guidance: Provides crucial information for future pregnancy decisions
- Peace of Mind: Reduces uncertainty and anxiety about your baby’s health status
- Timely Intervention: Allows for appropriate medical management from birth
Understanding Your Test Results
We understand that waiting for genetic test results can be stressful. Our comprehensive report includes:
- Clear explanation of any ITGA2B gene variations detected
- Detailed interpretation of what the results mean for your baby
- Guidance on next steps and recommended medical follow-up
- Access to genetic counselling to help you understand the implications
- Support resources for families dealing with platelet disorders
Remember: A positive result doesn’t necessarily mean your child will develop symptoms, but it does provide valuable information for proactive healthcare.
Transparent Pricing – Investing in Your Baby’s Health
| Test Option | Regular Price | Special Price | Savings |
|---|---|---|---|
| ITGA2B Gene Thrombocytopenia NGS Test | ZAR 9,350 | ZAR 6,700 | ZAR 2,650 |
Price includes comprehensive genetic analysis, detailed report, and genetic counselling session
Why Trust Oracle Genomics?
- Nationwide Coverage: Available in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
- Expert Hematology Specialists: Working with leading hematologists in platelet disorders
- 99.9% Accuracy: Using advanced NGS technology for reliable results
- Comprehensive Support: Genetic counselling included with every test
- Quick Turnaround: Results in 3-4 weeks
- Multiple Sample Options: Blood, extracted DNA, or simple blood spot on FTA card
Take the First Step Toward Your Baby’s Health Security
Don’t let uncertainty about inherited bleeding disorders create unnecessary worry. Our ITGA2B Gene Thrombocytopenia test provides the answers you need to make informed decisions about your newborn’s healthcare.
Limited Time Offer: Special pricing of ZAR 6,700 available for a limited period. Early detection can make all the difference for your baby’s health journey.
